Matt Hallam is a global executive leader with 20+ years across medtech, digital health, and clinical research. He has scaled businesses from startup to multimillion-dollar revenues, led APAC and US operations, and built cross-border teams. Career highlights include senior roles at Johnson & Johnson, Citeline, and Merit Medical, alongside founding Melbourne Scientific. Now CEO of ASME and Chief Revenue Officer at TrialKey, Matt brings expertise in commercialisation, clinical trials, and global strategy. As an AUSCEP mentor, he supports clinical entrepreneurs to scale innovation, navigate regulatory landscapes, and build sustainable, impactful ventures.